Most people on Qsymia lose between 5% and 10% of their starting body weight within the first year. For someone who weighs 250 pounds, that translates to roughly 12 to 25 pounds. The exact amount depends on your dose, how consistently you follow a reduced-calorie diet, and how your body responds to the medication. Clinical trials showed the top dose produced average losses near 10% of body weight, while the lower dose averaged closer to 5% to 7%.
What the Clinical Trials Found
Qsymia was tested in large clinical trials before FDA approval, and the results varied significantly by dose. At the recommended starting dose (7.5 mg phentermine / 46 mg topiramate), participants lost an average of about 7% of their body weight over one year. Those who moved up to the top dose (15 mg phentermine / 92 mg topiramate) lost closer to 10% on average. For comparison, participants taking a placebo and following the same diet and exercise plan lost only about 1% to 2%.
Those are averages, which means some people lost considerably more and others less. Roughly 70% of people on the top dose lost at least 5% of their body weight, and about 48% lost 10% or more. That top-end response, losing 10% or more, is where you start seeing real improvements in blood pressure, blood sugar, and cholesterol.
How Quickly Weight Loss Happens
Most of the weight loss on Qsymia occurs in the first six months. The medication works fastest in the early weeks when appetite suppression is strongest, and results tend to plateau between months six and twelve. This isn’t a sign the drug stopped working. It means your body has adjusted to a lower calorie intake and a new metabolic baseline.
The FDA built specific checkpoints into the dosing schedule to help you and your prescriber decide if the medication is working well enough to continue. After 12 weeks on the starting dose, you should have lost at least 3% of your baseline body weight. If you haven’t, the prescriber will increase you to the top dose. After another 12 weeks at the top dose, the threshold rises to 5%. If you still haven’t hit that mark, the recommendation is to stop taking Qsymia entirely, because continued treatment is unlikely to produce meaningful results.
How Qsymia Reduces Appetite
Qsymia combines two medications that attack hunger from different angles. Phentermine is a stimulant that triggers the release of norepinephrine and epinephrine, the same stress hormones that naturally suppress your appetite when you’re alert or active. It makes you feel less hungry and more energized. Topiramate, originally developed as a seizure medication, enhances feelings of fullness through its effects on brain signaling. The combination means you eat less without feeling like you’re white-knuckling through every meal.
This dual mechanism is why Qsymia tends to outperform either ingredient on its own. The two drugs allow lower doses of each, which reduces side effects compared to taking full-strength versions separately.
Who Can Get a Prescription
Qsymia is approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher if you also have at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol. It’s designed as an add-on to diet and exercise, not a replacement for them. People who combine Qsymia with consistent lifestyle changes tend to lose more weight and keep it off longer than those relying on the medication alone.
Side Effects to Expect
The most commonly reported side effects are tingling or numbness in the hands and feet (a well-known effect of topiramate), dry mouth, constipation, and an altered sense of taste that can make carbonated drinks or certain foods taste metallic or flat. Insomnia and a slight increase in heart rate are also common, especially in the first few weeks, because phentermine is a stimulant.
Most of these side effects are mild and tend to ease after the first month. The tingling sensation, while harmless, persists for some people throughout treatment. More serious but less common concerns include mood changes, difficulty concentrating, and kidney stones, all linked to the topiramate component.
One critical safety issue: topiramate is associated with a two- to five-fold increased risk of cleft lip and cleft palate in babies exposed during the first trimester of pregnancy. Because of this, women of reproductive age must have a negative pregnancy test before starting Qsymia, repeat testing monthly, and use effective contraception throughout treatment. If you become pregnant, the medication should be stopped immediately.
How the Dosing Schedule Works
You start with a low dose for the first two weeks (3.75 mg phentermine / 23 mg topiramate), then move up to the recommended dose of 7.5 mg / 46 mg. This gradual ramp-up helps your body adjust and minimizes side effects. If you need the top dose based on the 12-week checkpoint, there’s another two-week transition at 11.25 mg / 69 mg before reaching the maximum of 15 mg / 92 mg.
When it’s time to stop, you don’t quit abruptly. Topiramate can cause seizures if discontinued suddenly, so your prescriber will taper the dose down over one to two weeks.
What It Costs
Qsymia is available through home delivery and retail pharmacies. Through the manufacturer’s home delivery program, a 90-day supply costs $210, which works out to $70 per month. A 30-day supply at a retail pharmacy runs about $89 using a GoodRx discount. Costco members can access an exclusive cash price of $98 for a 30-day supply.
For patients paying cash or whose insurance doesn’t cover Qsymia, the manufacturer offers a savings card worth $80 off per 30-day fill for up to 100 refills. If your commercial insurance does cover the medication, you’re responsible for the first $70 of your copay and can get up to $65 off the remainder. These programs make Qsymia significantly cheaper than many newer injectable weight loss medications, which often run $1,000 or more per month without insurance.
How Qsymia Compares to Newer Options
Qsymia produces solid results, but the newer injectable medications (semaglutide and tirzepatide) generally produce larger average weight losses, often in the range of 15% to 20% of body weight. The trade-off is cost, accessibility, and route of administration. Qsymia is an oral capsule, substantially less expensive, and has been on the market since 2012 with a well-understood safety profile. For people who can’t access or tolerate injectables, or who prefer a pill, Qsymia remains one of the more effective prescription options available.
The 5% to 10% weight loss range that Qsymia reliably delivers is enough to produce measurable health benefits. Blood pressure drops, blood sugar improves, and the mechanical stress on joints decreases. For many people, that range represents the difference between needing medication for conditions like prediabetes and managing them through lifestyle alone.